$8.87
-0.98-9.95%
Last update: Nov 10, 5:06 PM
Capricor Therapeutics Inc (CAPR) Stock Price, Quote, News & History
CAPRNASDAQ
Capricor Therapeutics (NASDAQ:CAPR) held its third-quarter earnings conference call on Tuesday. Below is the complete transcript from the call.This transcript...
You can purchase shares of Capricor Therapeutics (NASDAQ:CAPR) through any online brokerage.
Other companies in Capricor Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Capricor Therapeutics has a consensus price target of $30.86.
The stock price for Capricor Therapeutics (NASDAQ: CAPR) is $9.2754 last updated November 10, 2026 at 5:06 PM EST.
There are no upcoming dividends for Capricor Therapeutics.
Capricor Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Capricor Therapeutics.
Capricor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in...
